UCLA Samueli to lead $4 million cell research project funded by Chan Zuckerberg Initiative
Key takeawaysThe grant will fund a three-year collaboration among researchers at UCLA, USC and Caltech to advance cell and tissue engineering technologies.The project, led by UCLA ’s Dino Di Carlo, will engineer, manipulate and analyze cell-to-cell interactions that underlie complex multicellular systems in the body.Di Carlo said he aims for the collaboration to develop into a long-term partnership across institutions to advance biotechnology in Los Angeles.The Chan Zuckerberg Initiativetoday announced a $4 million grant to support research led by the UCLA Samueli School of Engineering that will examine cellular behavio...
Source: UCLA Newsroom: Health Sciences - February 29, 2024 Category: Universities & Medical Training Source Type: news

Hologic AI-powered cancer screening system wins FDA approval
The digital cytology system helps identify cervical cancer cells and precancerous lesions using deep learning AI and volumetric imaging technology. (Source: mobihealthnews)
Source: mobihealthnews - February 9, 2024 Category: Information Technology Source Type: news

Cell biologist whose work spans over 30 years receives RMS Scientific Achievement Award
David Stephens, Emeritus Professor of Cell Biology in the School of Biochemistry, has been awarded the Royal Microscopical Society (RMS) Scientific Achievement Award for his work on cell biology. (Source: University of Bristol news)
Source: University of Bristol news - February 7, 2024 Category: Universities & Medical Training Tags: Grants and Awards, Research; Faculty of Life Sciences, Faculty of Life Sciences, School of Biochemistry; Press Release Source Type: news

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer
(MedPage Today) -- Artificial intelligence-driven analysis of blood samples showed potential for early diagnosis of ovarian cancer with 93% accuracy. (Georgia Tech, Gynecologic Oncology) Hologic announced FDA clearance of a digital cytology system... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2024 Category: Hematology Source Type: news

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024 -- (Healthcare Sales & Marketing Network) -- BD (Becton... Diagnostics, Oncology BD , Techcyte, cervical cancer, Pap smear (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 30, 2024 Category: Pharmaceuticals Source Type: news

Optimal Follow-up After Cervical Cancer Surgery Optimal Follow-up After Cervical Cancer Surgery
Instead of using a one-size-fits-all approach, monitoring for cancer recurrence after fertility-sparing cervical cancer surgery can be tailored based on HPV testing and cytology.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 3, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

Researcher loses disability lawsuit against major science funder
A jury in Maryland today delivered a unanimous verdict in favor of the Howard Hughes Medical Institute (HHMI), finding it did not discriminate against Vivian Cheung, a disabled biologist and physician, when it failed to renew her multimillion-dollar award in 2018. The closely watched case put a spotlight on obstacles faced by disabled scientists. Lawyer Chong Park of Ropes & Gray was successful in persuading a jury of four women and two men that HHMI and its reviewers treated Cheung like any other scientist when she competed unsuccessfully to renew her investigator award for RNA studies. At the end of an 8-day tr...
Source: ScienceNOW - December 14, 2023 Category: Science Source Type: news

Cyclacel Pharmaceuticals Announces Reverse Stock Split
BERKELEY HEIGHTS, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. CYCCCYCCP ", Cyclacel", or the ", Company", ))), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it will implement a 1-for-15 Reverse Stock Split…#berkeleyheights #cyclacel #nasdaqcapitalmarket #cycc #reversestocksplit #equinititrustcompany #llc #cdk29 #plk1 #allrightsreserved (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news

FDA Approves First CRISPR Treatment in U.S.
It was only 11 years ago that scientists Jennifer Doudna and Emmanuelle Charpentier first described a new way to edit genes, called CRISPR, in a scientific paper. The discovery is so game-changing that the pair earned the Nobel Prize in Chemistry in 2020 for how it could transform the way genetic diseases are treated. Now, on Dec. 8, the U.S. Food and Drug Administration (FDA) approved the very first treatment in the country based on the technology. [time-brightcove not-tgx=”true”] In the medical world, that’s lightning speed. “It’s incredible,” says Doudna, professor of chemistry a...
Source: TIME: Health - December 8, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

USPSTF-recommended screening leads to less cancer burden
Increasing use of recommended screening strategies could reduce the U.S. cancer burden, according to research published November 22 in JAMA Network Open. A team led by Amy Knudsen, PhD, from Massachusetts General Hospital in Boston found an increase of 10 percentage points in the uptake of lung, colorectal, breast, and cervical cancer screening at their respective starting ages as recommended by the U.S. Preventive Services Task Force (USPSTF) led to decreased cancer deaths. It highlighted that this could help the U.S. achieve the Cancer Moonshot initiative’s goals. “Achieving these reductions is predicated on ensuri...
Source: AuntMinnie.com Headlines - November 22, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Imaging Source Type: news

Meat made from cells, not livestock, is here. But will it ever replace traditional meat?
Cultivated chicken is processed at the Believer Meats facility in Rehovot, Israel on Feb. 13, 2023. The company is one of over 150 startups aiming to use cell biology to reduce the environmental impact of the world’s ever-increasing demand for meat and change global protein production. (AP…#rehovot #israel #emmahtobin #proteinproblem #yaakovnahmias #singapore #associatedpressnorc #tysonfoods #believer #nahmias (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2023 Category: Consumer Health News Source Type: news

Combining cell biology and bioengineering, researchers work to create 'mini kidney' for accurate testing
The research venture between Upstate and Syracuse University is funded by a grant from National Institute of Diabetes and Digestive and Kidney Diseases. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - November 16, 2023 Category: Universities & Medical Training Tags: News Research Source Type: news

British biotech races US ’s ‘buff billionaires’ for secret of eternal youth
The UK excels at ‘longevity research’. Could it become part of an industry that fascinates the wealthiest people in the world?About a decade ago, 125 amateur cyclists from all over the UK filed into the laboratories at King ’s College London. Aged between 55 and 79, they were there to participate in a long-term study examining how regular physical activity affects the ageing process.Janet Lord, professor of immune cell biology at Birmingham University, who conductedthe study in collaboration with King ’s professor Steve Harridge, said the team were surprised by some findings when they examined the cyclists’ bodie...
Source: Guardian Unlimited Science - November 5, 2023 Category: Science Authors: Julia Kollewe Tags: Biotechnology industry Ageing Business Science Genetics Technology startups Biology Source Type: news

Jennifer Loros Receives B.O. Dodge Award from Neurospora Research Community
Jennifer Loros, PhD, a professor of Biochemistry and Cell Biology and of Molecular and Systems Biology at Dartmouth’s Geisel School of Medicine, has received the 2023 B.O. Dodge Award from the Neurospora research community. (Source: News at Dartmouth Medical School)
Source: News at Dartmouth Medical School - October 31, 2023 Category: Hospital Management Authors: Timothy Dean Tags: News Jennifer Loros Molecular and Systems Biology Source Type: news

U.S. urges DNA synthesis firms to ramp up screening for biosecurity threats
Worried that bioterrorists will take advantage of the growing ease of creating risky pathogens in the lab, federal officials are beefing up guidelines for companies that sell nucleic acids such as DNA and RNA. The recommendations, released earlier this month, update the U.S. Department of Health and Human Services’s (HHS’s) 13-year-old guidance for screening orders to cover more forms of DNA and RNA, as well as new desktop devices for printing these molecular blueprints. Yet the guidelines will remain voluntary under HHS’s plan, disappointing some biosecurity experts. Biologists seeking to synthesize genes comm...
Source: ScienceNOW - October 23, 2023 Category: Science Source Type: news